These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8340529)

  • 41. Autoantibodies to the Rpp25 component of the Th/To complex are the most common antibodies in patients with systemic sclerosis without antibodies detectable by widely available commercial tests.
    Mahler M; Satoh M; Hudson M; Baron M; Chan JY; Chan EK; Wick J; Fritzler MJ;
    J Rheumatol; 2014 Jul; 41(7):1334-43. PubMed ID: 24931955
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The many faces of scleroderma.
    Steen VD
    Rheum Dis Clin North Am; 2008 Feb; 34(1):1-15; v. PubMed ID: 18329529
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Diagnostic significance of scleroderma and myositis-associated autoantibodies].
    Genth E; Mierau R
    Z Rheumatol; 1995; 54(1):39-49. PubMed ID: 7725809
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Autoantibodies in childhood scleroderma.
    Bernstein RM; Pereira RS; Holden AJ; Black CM; Howard A; Ansell BM
    Ann Rheum Dis; 1985 Aug; 44(8):503-6. PubMed ID: 3875322
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anti-(U1)RNP and anti-Sm autoantibody profiles in patients with systemic rheumatic diseases: differential detection of immunoglobulin G and M by immunoblotting.
    Guldner HH; Lakomek HJ; Bautz FA
    Clin Immunol Immunopathol; 1986 Sep; 40(3):532-8. PubMed ID: 3731543
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Autoantibodies against RNA polymerase I in scleroderma and Sjögren's syndrome sera.
    Stetler DA; Reichlin M; Berlin CM; Jacob ST
    Biochem Biophys Res Commun; 1987 May; 144(3):1296-302. PubMed ID: 3579959
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reactivity of anti-mitochondrial antibodies in primary biliary cirrhosis and systemic sclerosis.
    Chou MJ; Lai MY; Lee SL; Tsay GJ
    J Formos Med Assoc; 1992 Nov; 91(11):1075-80. PubMed ID: 1363208
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Autoantibodies to NOR 90/hUBF: longterm clinical and serological followup in a patient with limited systemic sclerosis suggests an antigen driven immune response.
    Dagher JH; Scheer U; Voit R; Grummt I; Lonzetti L; Raymond Y; Senécal JL
    J Rheumatol; 2002 Jul; 29(7):1543-7. PubMed ID: 12136917
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Are ACA and Scl 70 antibodies mutually exclusive?
    Jarzabek-Chorzelska M; Błaszczyk M; Kołacińska-Strasz Z; Jabłonska S; Chorzelski T; Maul GG
    Br J Dermatol; 1990 Feb; 122(2):201-8. PubMed ID: 2107867
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characteristic nucleolar-reticular immunofluorescence staining pattern on touch prints of hamster liver: a marker for Scl-70 antibody.
    Kühn G; Jarzabek-Chorzelska M; Kolacinska-Strasz Z; Blaszczyk M; Chorzelski TP; Jablonska S
    Int Arch Allergy Appl Immunol; 1989; 89(2-3):181-7. PubMed ID: 2668198
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of a high molecular weight acidic nuclear protein recognized by autoantibodies in sera from patients with polymyositis-scleroderma overlap.
    Mimori T; Akizuki M; Yamagata H; Inada S; Yoshida S; Homma M
    J Clin Invest; 1981 Sep; 68(3):611-20. PubMed ID: 7276162
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antibodies to topoisomerase I in sera from patients with scleroderma.
    Shero JH; Bordwell B; Rothfield NF; Earnshaw WC
    J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():138-40. PubMed ID: 3039129
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Autoantibodies in systemic sclerosis.
    Steen VD
    Semin Arthritis Rheum; 2005 Aug; 35(1):35-42. PubMed ID: 16084222
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The pathogenic role of autoantibodies to nuclear autoantigens in systemic sclerosis (scleroderma).
    Senécal JL; Hénault J; Raymond Y
    J Rheumatol; 2005 Sep; 32(9):1643-9. PubMed ID: 16142854
    [No Abstract]   [Full Text] [Related]  

  • 55. Recently characterised autoantibodies and their clinical significance.
    Sturgess A
    Aust N Z J Med; 1992 Jun; 22(3):279-89. PubMed ID: 1497555
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Autoantibodies in scleroderma.
    Rothfield NF
    Rheum Dis Clin North Am; 1992 May; 18(2):483-98. PubMed ID: 1626078
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Autoantibody detection in scleroderma patients. Diagnostic and analytical performances of a new coupled particle light scattering immunoassay.
    Bizzaro N; Bonelli F; Tonutti E; Villalta D; Tozzolis R
    Clin Exp Rheumatol; 2002; 20(1):45-51. PubMed ID: 11892707
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A cross-sectional study of autoantibody profiles in the Waikato systemic sclerosis cohort, New Zealand.
    Chang WS; Schollum J; White DH; Solanki KK
    Clin Rheumatol; 2015 Nov; 34(11):1921-7. PubMed ID: 26022620
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison between counterimmunoelectrophoresis and double radial immunodiffusion in the detection of antibodies to topoisomerase I in sera from scleroderma patients.
    Asero R; Origgi L; D'Agostino P; Bertetti E; Riboldi P
    Boll Ist Sieroter Milan; 1988; 67(2):159-61. PubMed ID: 3147686
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Protective Effect Against Cancer of Antibodies to the Large Subunits of Both RNA Polymerases I and III in Scleroderma.
    Shah AA; Laiho M; Rosen A; Casciola-Rosen L
    Arthritis Rheumatol; 2019 Sep; 71(9):1571-1579. PubMed ID: 30888702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.